Showing results (121-130 of 236) with videos related to
Sort By:
Pageof 24
Archives of Internal Medicine|May 22, 2002
Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5Guillermo Ruiz-Irastorza, Munther A Khamashta, Beverley J Hunt, et al.Perfusion|August 2, 2018
A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep deviceGethin Boyle, Agnieszka Kuffel, Kiran Parmar, et al.American Journal of Obstetrics and Gynecology|July 26, 2011
Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndromeBeverley J Hunt, Xiao-Xuan Wu, Bas de Laat, et al.The New England Journal of Medicine|August 11, 2021
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and ThrombosisSue Pavord, Marie Scully, Beverley J Hunt, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 18, 2014
The utility of the Wells clinical prediction model and ventilation-perfusion scanning for pulmonary embolism diagnosis in pregnancyBriony A Cutts, Huyen A Tran, Eileen Merriman, et al.Journal of Thrombosis and Haemostasis : JTH|March 2, 2023
Decision-analysis modeling of effectiveness and cost-effectiveness of pharmacologic thromboprophylaxis for surgical inpatients using variable risk assessment models or other strategiesSarah Davis, Steve Goodacre, Daniel Horner, et al.Journal of Thrombosis and Haemostasis : JTH|January 12, 2024
Estimating the value of future research into thromboprophylaxis for women during pregnancy and after delivery: a value of information analysisSarah Davis, Abdullah Pandor, Fiona C Sampson, et al.BMJ Medicine|February 23, 2024
Effectiveness and cost effectiveness of pharmacological thromboprophylaxis for medical inpatients: decision analysis modelling studySarah Davis, Steve Goodacre, Daniel Horner, et al.Brain : a Journal of Neurology|November 11, 2003
Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunctionAhamad Hassan, Beverley J Hunt, Michael O'Sullivan, et al.BMJ (Clinical Research Ed.)|September 13, 2012
Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trialIan Roberts, Pablo Perel, David Prieto-Merino, et al.Pageof 24